STX6

STX6 (syntaxin-6) is a Q-SNARE protein that mediates membrane fusion across multiple Golgi and endosomal trafficking pathways (PMID:37996040, PMID:34476885). As a core fusogen it assembles a Q-SNARE complex with STX7 and VTI1B that pairs with the R-SNARE VAMP4 on Golgi-derived vesicles to drive their fusion with late endosomes, a route that controls delivery of MT1-MMP to the cell surface and consequent matrix degradation in activated macrophages (PMID:34476885). In a distinct fusion event, STX6 is recruited to GAS-containing autophagosome-like vacuoles through its tyrosine-based sorting motif and transmembrane domain, where it forms a SNARE complex with VTI1B and VAMP3 to fuse recycling endosomes with these vacuoles during xenophagy of Group A Streptococcus, a step dependent on RABGEF1 (PMID:27791468). Beyond its fusogenic role, at the Golgi STX6 forms a complex with CAL and CFTR and recruits the E3 ubiquitin ligase MARCH2, synergistically enhancing MARCH2 binding to CAL to drive ubiquitination and lysosomal degradation of mature CFTR (PMID:23818989). Genetic ablation of Stx6 in mice modestly prolongs prion disease incubation, consistent with a function in early-endosome-to-trans-Golgi-network retrograde transport relevant to prion pathogenesis, while leaving animals otherwise viable and unimpaired (PMID:37996040). Additional cellular roles include support of cancer cell proliferation and integrin trafficking (PMID:26906622) and, as a direct target of miR-375-3p, restraint of endothelial cell senescence via the SMAD2/p15 pathway (PMID:41367311).

1. 2013 High

   Established that STX6 acts beyond vesicle fusion by serving as a scaffold that couples an E3 ligase to a cargo at the Golgi, defining a route for CFTR quality-control degradation.

   Evidence Reciprocal Co-IP, in vivo ubiquitination assay, siRNA knockdown, and catalytic/PDZ-motif mutants in cells

   PMID:23818989

   Open questions at the time

   • Whether STX6's SNARE/fusion activity is required for the MARCH2-CAL-CFTR scaffolding role is not separated
   • Structural basis of STX6-driven enhancement of MARCH2-CAL binding unresolved
2. 2016 High

   Showed STX6 directs a specific fusion event in antibacterial autophagy, defining the SNARE partners and recruitment determinants that fuse recycling endosomes with pathogen-containing vacuoles.

   Evidence Knockout/knockdown with xenophagy phenotype, Co-IP, domain mutant analysis, live imaging, RABGEF1 epistasis

   PMID:27791468

   Open questions at the time

   • Mechanism by which RABGEF1 promotes assembly of the STX6-VAMP3-VTI1B complex not detailed
   • Generality of this SNARE set beyond Group A Streptococcus xenophagy unknown
3. 2016 Low

   Linked STX6 to cancer cell proliferation and migration, implicating it in p53-dependent growth control and integrin trafficking.

   Evidence siRNA silencing with viability, proliferation, integrin trafficking, and migration assays in ESCC cells

   PMID:26906622

   Open questions at the time

   • KD phenotype without detailed pathway mechanistic validation; integrin-trafficking link stated but not deeply characterized
   • How STX6 connects mechanistically to p53 is undefined
   • Single lab, single cancer model
4. 2021 Medium

   Defined the trans-SNARE pairing (STX6/STX7/VTI1B with VAMP4) for Golgi-to-late-endosome fusion and tied it to a functional cargo output, surface MT1-MMP and matrix degradation.

   Evidence Fixed/live imaging, siRNA depletion with gelatin degradation readout, overexpression rescue in LPS-activated macrophages

   PMID:34476885

   Open questions at the time

   • Single lab with two orthogonal methods; not independently reconstituted
   • Regulation of complex assembly in response to LPS not resolved
5. 2023 Medium

   Tested the physiological requirement for STX6 in vivo, showing it is dispensable for development but modulates prion disease progression, consistent with its retrograde transport role.

   Evidence Stx6 knockout mouse, RML/ME7 prion inoculation, histopathology

   PMID:37996040

   Open questions at the time

   • Modest effect size (~12 day extension) from a single study
   • Direct molecular link between STX6 retrograde transport and prion propagation not established
6. 2025 Medium

   Positioned STX6 as a miRNA-regulated node controlling endothelial senescence, identifying it as a direct miR-375-3p target acting through SMAD2/p15.

   Evidence Luciferase 3'UTR reporter, STX6 overexpression rescue, ApoE-/- mouse with miR-375-3p inhibition, SA-β-gal and Western blot

   PMID:41367311

   Open questions at the time

   • How STX6 trafficking activity mechanistically couples to SMAD2/p15 signaling is unspecified
   • Single lab

• How STX6's diverse fusion and scaffolding activities are spatially and temporally partitioned among its distinct SNARE partners and cargoes remains unresolved.
• No structural model of STX6 trans-SNARE complexes in the corpus
• Determinants selecting between STX7/VTI1B/VAMP4 versus VTI1B/VAMP3 partnerships unknown
• Mechanism connecting trafficking activity to downstream signaling outcomes (p53, SMAD2/p15) uncharacterized